Your browser doesn't support javascript.
loading
Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment-naïve, noncirrhotic HCV genotype 3-infected patients.
Gane, E; Nahass, R; Luketic, V; Asante-Appiah, E; Hwang, P; Robertson, M; Wahl, J; Barr, E; Haber, B.
Affiliation
  • Gane E; Auckland Clinical Studies, Grafton, Auckland, New Zealand.
  • Nahass R; ID Care, Hillsborough, NJ, USA.
  • Luketic V; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
  • Asante-Appiah E; Hunter Holmes McGuire Department of Veterans Affairs Medical Center, Richmond, VA, USA.
  • Hwang P; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Robertson M; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Wahl J; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Barr E; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Haber B; Merck & Co., Inc., Kenilworth, NJ, USA.
J Viral Hepat ; 24(10): 895-899, 2017 10.
Article in En | MEDLINE | ID: mdl-28470815
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Quinoxalines / Ribavirin / Benzofurans / Hepatitis C / Hepacivirus / Genotype / Imidazoles Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2017 Type: Article Affiliation country: New Zealand
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Quinoxalines / Ribavirin / Benzofurans / Hepatitis C / Hepacivirus / Genotype / Imidazoles Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2017 Type: Article Affiliation country: New Zealand